A. A. Poliakova

A. A. Poliakova

Auto-generated profile, based on publicly available information

A. A. Poliakova

Pavlov University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AGA Y Gudkova
A Y Gudkova
SLS V Lapekin
S V Lapekin
TBT G Bezhanishvili
T G Bezhanishvili
MTM A Trukshina
M A Trukshina
VDV G Davydova
V G Davydova
ESE V Shlyakhto
E V Shlyakhto
There are presented the literature data and a description of the clinical course of the disease in isolated/predominant cardiac amyloidosis. Amyloid cardiomyopathy is the most common phenocopy of hypertrophic cardiomyopathy. The modern possibilities of non-invasive diagnostics using osteoscintigraphy for the differential diagnosis between amyloid cardiomyopathy caused by AL- and transthyretin amyloidosis are described in detail.

3 November 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ASA. A. Streltsova
A. A. Streltsova
AGA. Y. Gudkova
A. Y. Gudkova
APA. A. Poliakova
A. A. Poliakova
SPS. A. Pyko
S. A. Pyko
AKAnna Kostareva
Anna Kostareva
Aim. To determine the impact of polymorphic variant rs1739843 of the HSPB7 gene on clinical profile and outcomes in patients with hypertrophic cardiomyopathy (HCM).Material and methods. The study population consisted of 108 patients with HCM ≥45 years old. The control group included 192 healthy donors. The design of the study included an assessment of the clinical course, determining the outcome of HCM using a new methodological approach proposed by Rowin EJ, et al. (2017). Polymorphic variant rs1739843 of the HSPB7 gene was genotyped by allele-specific real-time polymerase chain reaction (PCR) assay.Results. It was found a significant increase in frequency of TT genotype of rs1739843 of the HSPB7 gene in patients with HCM — 20,4%, compared with control group — 4,2% (ТТ: ТС+СС, odds ratio (OR) =5,88, 95% confidence interval (CI) =2,52-13,75, p<0,001). High prevalence of CC genotype of rs1739843 of the HSPB7 gene was observed in control group — 80,2% vs 31,5% in HCM group (CC: ТС+TT, OR=0,11, 95% CI=0,07-0,19, p<0,001). The allele frequency (С:Т) also differs between HCM and control groups — 55,6:44,4% in HCM vs 88,02:11,98% in control group (OR=5,88, 95% CI=3,91-8,85, p<0,001). It was also found a significant increase in frequency of TT genotype and T allele of rs1739843 of the HSPB7 gene in HCM patients with oligosymptomatic HCM course — 16,7%, compared with control group — 4,2% (ТТ: ТС+СС, OR=4,60, 95% CI=1,63-12,99, p<0,001). HCM patients ≥45 years old showed a significant increase in T allele frequency in cases of presence of 2 (FC III-IV CHF (chronic heart failure)+AF (atrial fibrillation), 18,8% vs 6,6%) and 3 adverse pathways (FC III-IV CHF+AF+SCD (sudden cardiac death), 4,2% vs 1,6%).Conclusion. HCM progression along 2 and more adverse pathways in patients ≥45 years old has been characterized with adverse outcome. The T allele and TT genotype of rs1739843 of the HSPB7 gene were more frequent in patients with HCM ≥45 years old, compared with control group. It was also found a significant increase in frequency of TT genotype and T allele of rs1739843 of the HSPB7 gene in HCM patients with oligosymptomatic HCM course, compared with control group.Allele T of rs1739843 of the HSPB7 gene is associated with 2 and more adverse pathways of HCM progression.

9 March 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
APA. A. Poliakova
A. A. Poliakova
EBE. I. Baranova
E. I. Baranova
ESE. N. Semernin
E. N. Semernin
AKA. N. Krutikov
A. N. Krutikov
ОМО. В. Мельник
О. В. Мельник
AGA. Ya. Gudkova
A. Ya. Gudkova
ГЕНДЕРНЫЕ РАЗЛИЧИЯ КЛИНИЧЕСКОГО ТЕЧЕНИЯ И РЕМОДЕЛИРОВАНИЯ СЕРДЦА ПРИ ИДИОПАТИЧЕСКОЙ ГИПЕРТРОФИЧЕСКОЙ КАРДИОМИОПАТИИ В ПОЖИЛОМ ВОЗРАСТЕ

9 March 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ESE. V. Shlyakhto
E. V. Shlyakhto
APA. A. Poliakova
A. A. Poliakova
ESE. N. Semernin
E. N. Semernin
AKA. N. Krutikov
A. N. Krutikov
AОA. Е. Оksas
A. Е. Оksas
AGA. Ya. Gudkova
A. Ya. Gudkova
АКРОМЕГАЛИЧЕСКАЯ КАРДИОМИОПАТИЯ С ДИНАМИЧЕСКОЙ ОБСТРУКЦИЕЙ ВЫНОСЯЩЕГО ТРАКТА ЛЕВОГО ЖЕЛУДОЧКА

7 September 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VDV. G. Davydova
V. G. Davydova
AGA. Ya. Gudkova
A. Ya. Gudkova
AKA. N. Krutikov
A. N. Krutikov
APA. A. Poliakova
A. A. Poliakova
AKAnna Kostareva
Anna Kostareva
Aim. To study the clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy (HCM) with indications for primary and secondary prevention of sudden cardiac death (SCD).Material and methods. The study included 44 young patients with HCM who were examined in accordance with national clinical guidelines for HCM (2020). The AHA HCM SCD Calculator was used to calculate the risk of SCD. The genetic study was performed using a target panel of 108 genes associated with cardiomyopathies.Results. In the study cohort, young patients in 72,7% of cases (n=32) had from 1 to 3 cardiometabolic risk factors (on average 1,53±0,8).The age of 18 patients with indications for implantable cardioverter-defibrillator (ICD) ranged from 18 to 44 years (28,8±2,2). The age at diagnosis was 18,5±7,4 years, while the asymptomatic period lasted 6,4±0,9 years. The estimated risk of SCD ranged from 3,11 to 20,71% (6,15 [4,67; 7,32]). In 83,3% of cases (n=15), familial HCM was diagnosed, while 50% (n=9) had a positive family history of SCD. In the subgroup of patients with indications for ICD, genetic variants with pathogenic significance (class IV and V) encoding the production of sarcomere proteins were detected in 6 of 9 probands (66,7%).In patients with indications for ICD (n=18), compared to patients without it (n=26), the diagnosis of HCM was more often established in childhood and adolescence (61,1% vs 23%, p=0,01). In patients with indications for ICD, the reverse curvature hypertrophy of the interventricular septum was significantly more often diagnosed (72,2% vs 38,5%, p=0,028). Among patients with indications for ICD, the proportion of people with low physical activity was 50% (n=9), of which 55,6% (n=5) were diagnosed with overweight/class 1 obesity.Conclusion. Childhood and adolescence at the time of diagnosis of HCM and reverse curvature hypertrophy of the interventricular septum are significantly more common in young patients with indications for ICD.

26 November 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
APA. Poliakova
A. Poliakova
AKA. Krutikov
A. Krutikov
ESE. Semernin
E. Semernin
AKAnna Kostareva
Anna Kostareva
AGA. Gudkova
A. Gudkova